Latest news with #AllPennyStocks.comMedia
Globe and Mail
02-05-2025
- Business
- Globe and Mail
Biotech Stock Ends Week On High Note Following Bullish Coverage Initiation
A New Jersey-based biotech found success to finish out the week after it was announced that TD Cowen initiated coverage on the company with a buy rating and a price target of $12. Seeing that this micro cap closed yesterday at just $2.71, it's now wonder traders rushed in. So far this session, the buying pressure was enough to get shares of Grace Therapeutics Inc. (Nasdaq:GRCE) up to $2.8604/share (+5.55%) at the early session high. This move is a strong continuation of the success this stock has had so far this month. Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada. The company's lead product candidate is the GTX-104, an intravenous infusion to treat subarachnoid hemorrhage. It also develops GTX-102, an oral mucosal betamethasone spray for the treatment of ataxia-telangiectasia; and GTX-101, a topical bioadhesive film-forming bupivacaine spray for postherpetic neuralgia. The company was formerly known as Acasti Pharma Inc. and changed its name to Grace Therapeutics, Inc. in October 2024. The company was incorporated in 2002 and is headquartered in Princeton, New Jersey. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
Globe and Mail
30-04-2025
- Business
- Globe and Mail
Mining Stock Surges Mid-Week After Strong Q1 Earnings
A Toronto-based mining company found a tremendous amount of success on Wednesday after the company reported better-than-expected Q1 results, according to a release. The company had revenues for the quarter ended March 31 of $209.1 million, up from $192.1 million a year earlier. Traders liked what they saw as they snatched up shares of New Gold Inc. (NYSE American:NGD), pushing the mining stock up to $3.94/share (+17.61%) at the early session high. This move is a strong continuation of the success this stock has had over the last few months. New Gold Inc is an intermediate gold mining company. The company has a portfolio of two producing assets: Rainy River Mine and New Afton Mine in Canada. Also, it has interests in the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of Gold, Copper, and Silver. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
Globe and Mail
30-04-2025
- Business
- Globe and Mail
Biotech Stock Soars Over 100% On Premarket Following Acquisition Announcement
A California-based biotech company is absolutely stealing the spotlight after it was announced that Novartis AG is set to acquire it. The press release mentions that Novartis is to acquire the company 'for $7.00 per share in cash, with potential to receive an additional $7.00 per share in cash through a contingent value right, for a total equity value of up to approximately $1.7 billion.' Seeing that Regulus Therapeutics Inc. (Nasdaq:RGLS) closed at just $3.37 on Tuesday, it's no wonder that shares of this small cap are already off to the races, with traders currently bid at $7.82/share (132.05% implied open for sellers). Be sure to keep your eye on this one! Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome. The company partnered with Sanofi to create a compound targeting orphan diseases and with AstraZeneca to cure Type 2 Diabetes/prediabetes. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
Globe and Mail
25-04-2025
- Business
- Globe and Mail
Small Cap Rallies Late In Week On Q1 Earnings Report
A Massachusetts-based battery tech company turned heads on Friday after the company reported better-than-expected Q1 EPS results and authorized a $30 million share repurchase program, according to a press release. Traders wasted no time buying up shares of SES AI Corporation Class A (NYSE:SES), pushing the small cap up to $1.25/share (+43.86%) at the early session high. This move was a strong continuation of the success this stock has had so far this month and solidifies that the stock is breaking out of a previously-established downtrend since the beginning of this year. SES AI Corp is engaged in the development and initial production of high-performance Lithium-Metal (Li-Metal) rechargeable battery technologies for electric vehicles (EVs), electric vehicle take-off and landing (eVTOL), and other applications. The company is an integrated Li-Metal battery manufacturer with capabilities in material, cell, module, AI-powered safety algorithms, and recycling. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
Globe and Mail
16-04-2025
- Business
- Globe and Mail
Pharmaceutical Stock Jumps After Key Trial Findings
A pharmaceuticals company based out of Maryland is turning heads on Wednesday after the company announced that data demonstrated the potential efficacy of its oral ketamine analog, Ketamir-2, in treating diabetic neuropathy in animal model, according to a press release from this morning. Traders wasted little time buying up shares of MIRA Pharmaceuticals Inc. (Nasdaq:MIRA), thrusting the micro cap up to $1.33/share (+48.24%) at the early session high. This move could indicate a breakout is imminent as this stock fights to breakout of a multi-month downtrend. MIRA Pharmaceuticals, Inc. operates as a clinical development stage biopharmaceutical company. The company focuses on the development and commercialization of a new molecular synthetic tetrahydrocannabinol (THC) analog under investigation for the treatment of adult patients with anxiety and cognitive decline typically associated with early-stage dementia. It is developing MIRA1a, a synthetic cannabinoid analog to treat anxiety and chronic pain by targeting the cannabinoid type 1 and type 2 receptors. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is headquartered in Baltimore, Maryland. Copyright © 2025 All rights reserved. Republication or redistribution of content is expressly prohibited without the prior written consent of shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. View more of this article on About Media, Inc.: Founded in 1999, is one of North America's leading platforms for micro-cap insights. Catering to both Canadian and U.S. markets, we provide a wealth of resources and expert content designed for everyone—from beginner investors to seasoned traders. is rapidly gaining recognition as a leading authority in the micro-cap space, with our insightful content prominently featured across numerous top-tier financial platforms, reaching a broad audience of investors and industry professionals. Want to showcase your company's story to a powerful network of investors? We can help you elevate your message and make a lasting impact. Contact us today. Contact: Media, Inc.
